There is a wide spectrum of non-carcinogenic AHR agonists, such as those naturally originated flavonoids, indole derivatives, tryptophan metabolites, etc., that may be applied for boosting the tumor suppressor-like activity of AHR. The gene discussed is AHR; the disease is neoplasm.